{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

MissionIRNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Completes Kyrgyz Gold Joint Venture, Advances Tulkubash Development

May 21, 2026This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) completed the conversion of Chaarat ZAAV CJSC into a joint venture company with Kyrgyzaltyn, a wholly owned entity of the Kyrgyz Republic, with Silvercorp holding a 70% interest as operator and Kyrgyzaltyn retaining a 30% free-carried interest.


InvestorNewsBreaks – American Fusion Inc. (OTC: AMFN) Files First Quarterly Report Following Kepler Transaction

May 21, 2026American Fusion (OTC: AMFN), a company developing advanced fusion energy technologies, including its Texatron(TM) Fusion Engine(TM) platform, filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, marking its first quarterly report reflecting the consolidated operations of American Fusion and Kepler Fusion Technologies following the closing of the previously announced reverse-merger share exchange on Feb. 27, 2026.


BioMedNewsBreaks — Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering

May 20, 2026Sunshine Biopharma (NASDAQ: SBFM) announced the closing of its previously announced public offering, generating approximately $6 million in gross proceeds before fees and expenses through the sale of 12 million common units, each including common stock or pre-funded warrants and two Series C warrants. The company said net proceeds will be used for general corporate purposes and working capital, with potential additional gross proceeds of approximately $12 million if the Series C warrants are fully exercised for cash, while Aegis Capital acted as exclusive placement agent.


Forward Industries Inc. (NASDAQ: FWDI) Announces Q2 2026 Financial and Operational Results

May 20, 2026 Forward Industries recently announced both financial and operational results for Q2 2026, a quarter which it said was defined by disciplined execution across the business. The Q2 highlights for Forward included appointing a new CFO, executing a share repurchase, securing a $40 million institutional debt facility, completing a minority investment in OnRe, and implementing a cost reduction plan.


NetworkNewsBreaks – Ideal Power Inc. (NASDAQ: IPWR) Secures $30 Million Financing to Accelerate B-TRAN Commercialization

May 20, 2026Ideal Power (NASDAQ: IPWR) announced a definitive agreement with institutional investors for a $30 million registered direct offering priced at the market under Nasdaq rules, with proceeds expected to support commercialization of its B-TRAN(R) bidirectional semiconductor power switch, including customer design-ins, custom development programs and initial production ramp efforts with strategic partners. Titan Partners, a division of American Capital Partners, is acting as sole placement agent for the financing, which the company said strengthens its balance sheet as it pursues growing opportunities tied to power efficiency demand across data center and industrial markets.


MissionIRNewsBreaks – Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast

May 20, 2026Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics and artificial intelligence.


AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Forms DelivMeds AI Venture Through Wellgistics Partnership and Strategic Acquisitions

May 20, 2026Datavault AI (NASDAQ: DVLT) announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform combining AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification and direct-to-consumer healthcare delivery through three concurrent transactions, including an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.